Lusayan, Peah P.
HRN: 22-40-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/27/2023
MUPIROCIN 2%, 15G (TUBE)
10/27/2023
10/31/2023
TOPICAL
Apply Thinly
BIDA
Post Op Site Infection
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes